# Qilu Pharmaceutical (Hainan) Co. Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/qilu-pharmaceutical-hainan-co-ltd/60dedaab-e32c-493a-894b-9eec7372c066

> Inspection records and compliance data for Qilu Pharmaceutical (Hainan) Co. Ltd. in Haikou, None. Access full analysis and detailed observations.

---

## Details

- Name: Qilu Pharmaceutical (Hainan) Co. Ltd.
- FEI Number: 3008250362
- City: Haikou
- State: None
- Country Name: China
- Address Line 1: No. 273-A Nanhai Avenue, Changliuzhen Xiuying
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1281926 - Qilu Pharmaceutical (Hainan) Co. Ltd. - 2025-08-22](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/767c8add-29d3-4bb2-aa95-0b733a0ece90) — source: FDA, date: August 22, 2025
- [FDA Inspection 1209088 - Qilu Pharmaceutical (Hainan) Co. Ltd. - 2023-05-19](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/6e8bd43e-ed93-47e5-874e-e0800b7e48d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2023
- [483 - Qilu Pharmaceutical (Hainan) Co. Ltd. - 2019-11-06](https://www.keypedia.com/records/483/qilu-pharmaceutical-hainan-co-ltd/723eae93-3a14-4608-bbf6-fb6e3f0a7637) — source: FDA, date: November 6, 2019
- [FDA Inspection 1111054 - Qilu Pharmaceutical (Hainan) Co. Ltd. - 2019-11-06](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/82214876-7e78-4952-b51e-a5128b2e1651) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 6, 2019
- [FDA Inspection 1036684 - Qilu Pharmaceutical (Hainan) Co. Ltd. - 2017-11-17](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/9b1c4308-e142-43a9-a008-cdbde2713b04) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2017
- [FDA Inspection 984197 - Qilu Pharmaceutical (Hainan) Co. Ltd. - 2016-08-02](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/477d4004-1a39-469d-99c5-b38be9e61a76) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 2, 2016
- [FDA Inspection 880306 - Qilu Pharmaceutical (Hainan) Co. Ltd. - 2014-05-23](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/f1601eb0-93ee-46e7-a66f-1f0cc41a8bd0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2014

## Related Companies

- [BioDuro, LLC](https://www.keypedia.com/companies/bioduro-llc/ea6debd9-54f2-4570-a8b6-f62b6f60c207)
- [Mayne Pharma International PTY LTD](https://www.keypedia.com/companies/mayne-pharma-international-pty-ltd/073fd71d-43f6-4a53-9597-0951e7459d08)
- [Cosette Pharmaceuticals NC Laboratories, LLC](https://www.keypedia.com/companies/cosette-pharmaceuticals-nc-laboratories-llc/4f90e360-99ea-4457-a022-4950a8ea7644)
- [Octapharma AB](https://www.keypedia.com/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262)
- [Mipharm S.p.A.](https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc)
- [Summit Biosciences Inc.](https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/adf0ad1b-ed79-4d72-a254-d42d5a982384)
- [Colgate-Palmolive Company](https://www.keypedia.com/companies/colgate-palmolive-company/7db665f6-094f-4de5-bf3b-c2528e2a223b)
- [PF Soins de Sante SRI](https://www.keypedia.com/companies/pf-soins-de-sante-sri/9e60bbed-a0ce-4353-ae08-a599608d5bd4)
- [Vee Pak, LLC](https://www.keypedia.com/companies/vee-pak-llc/db6ee2df-3da4-447c-be7a-d6c3d854af73)

## Related Officers

- [Joel D. Hustedt](https://www.keypedia.com/people/joel-d-hustedt/29440042-08dd-4dce-be48-b55f8e1d7080)